These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3741774)

  • 1. A comparison of fibrinolytic and defibrinating agents in established experimental glomerulonephritis.
    Tipping PG; Thomson NM; Holdsworth SR
    Br J Exp Pathol; 1986 Aug; 67(4):481-91. PubMed ID: 3741774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ancrod and rtPA on fibrin accumulation, glomerular inflammation and renal function in nephrotoxic nephritis.
    Mathieson PW; Thiru S; Peters DK; Oliveira DB
    Int J Exp Pathol; 1991 Dec; 72(6):679-93. PubMed ID: 1768613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defibrination with ancrod in nephrotoxic nephritis in rabbits.
    Thomson NM; Moran J; Simpson IJ; Peters DK
    Kidney Int; 1976 Nov; 10(5):343-7. PubMed ID: 794557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolytic therapy with streptokinase for established experimental glomerulonephritis.
    Tipping PG; Holdsworth SR
    Nephron; 1986; 43(4):258-64. PubMed ID: 3736736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effects.
    Kim S; Wadhwa NK; Kant KS; Pollak VE; Glas-Greenwalt P; Weiss MA; Hong CG
    Q J Med; 1988 Nov; 69(259):879-905. PubMed ID: 3078212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrin independent proinflammatory effects of tissue factor in experimental crescentic glomerulonephritis.
    Cunningham MA; Kitching AR; Tipping PG; Holdsworth SR
    Kidney Int; 2004 Aug; 66(2):647-54. PubMed ID: 15253718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis.
    Erlich JH; Holdsworth SR; Tipping PG
    Am J Pathol; 1997 Mar; 150(3):873-80. PubMed ID: 9060825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of defibrination with ancrod in experimental allergic glomerular injury.
    Naish PF; Evans DJ; Peters DK
    Clin Exp Immunol; 1975 May; 20(2):303-9. PubMed ID: 1212811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative evaluation of anticoagulants in experimental nephrotoxic nephritis.
    Thomson NM; Simpson IJ; Peters DK
    Clin Exp Immunol; 1975 Feb; 19(2):301-8. PubMed ID: 1212801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of defibrination on macrophage participation in rabbit nephrotoxic nephritis: studies using glomerular culture and electronmicroscopy.
    Holdsworth SR; Thomson NM; Glasgow EF; Atkins RC
    Clin Exp Immunol; 1979 Jul; 37(1):38-43. PubMed ID: 487657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit.
    Holdsworth SR; Tipping PG
    J Clin Invest; 1985 Oct; 76(4):1367-74. PubMed ID: 4056035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defibrination with ancrod in glomerulonephritis: effects on clinical and histologic findings and on blood coagulation.
    Pollak VE; Glueck HI; Weiss MA; Lebron-Berges A; Miller MA
    Am J Nephrol; 1982; 2(4):195-207. PubMed ID: 6816068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of C3 in the autologous phase of nephrotoxic nephritis.
    Thomson NM; Naish PF; Simpson IJ; Peters DK
    Clin Exp Immunol; 1976 Jun; 24(3):464-73. PubMed ID: 939050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue plasminogen activator therapy of rabbit nephrotoxic nephritis.
    Zoja C; Corna D; Macconi D; Zilio P; Bertani T; Remuzzi G
    Lab Invest; 1990 Jan; 62(1):34-40. PubMed ID: 1688634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular fibrinolytic activity during nephrotoxic nephritis.
    Giroux L; Verroust P; Morel-Maroger L; Delarue F; Delauche M; Sraer JD
    Lab Invest; 1979 Apr; 40(4):415-22. PubMed ID: 431041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of the effects of platelet depletion in the autologous phase of nephrotoxic serum nephritis.
    Sindrey M; Marshall TL; Naish P
    Clin Exp Immunol; 1979 Apr; 36(1):90-6. PubMed ID: 157239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of tissue plasminogen activator-induced fibrinolysis by activated protein C in endotoxin-treated rabbits.
    Krishnamurti C; Young GD; Barr CF; Colleton CA; Alving BM
    J Lab Clin Med; 1991 Dec; 118(6):523-30. PubMed ID: 1744501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-glomerular basement membrane antibody-induced experimental glomerulonephritis: evidence for dose-dependent, direct antibody and complement-induced, cell-independent injury.
    Boyce NW; Holdsworth SR
    J Immunol; 1985 Dec; 135(6):3918-21. PubMed ID: 4067309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The macrophage in the development of experimental crescentic glomerulonephritis. Studies using tissue culture and electron microscopy.
    Thomson NM; Holdsworth SR; Glasgow EF; Atkins RC
    Am J Pathol; 1979 Feb; 94(2):223-40. PubMed ID: 371409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The participation of macrophages, glomerular procoagulant activity, and factor VIII in glomerular fibrin deposition. Studies on anti-GBM antibody-induced glomerulonephritis in rabbits.
    Tipping PG; Holdsworth SR
    Am J Pathol; 1986 Jul; 124(1):10-7. PubMed ID: 3089018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.